The law firm Smart & Biggar recently published an overview of some key developments for biosimilars in Canada, including approvals, pending submissions and litigation. Health Canada has approved 36 biosimilars to date and has 16 biosimilar submissions under review.
Who we are
Biosimilars Canada is a national association representing the biosimilar medicines industry in Canada. We provide leadership in educating Canadian stakeholders about the safety and efficacy of biosimilar medicines, and advocate for policies that support their timely approval, reimbursement, market acceptance and expanded use.
Learn more about biosimilars and their benefits for patients and healthcare systems.
For Alberta and Green Shield Canada savings are beginning to add up from switching initiatives for multiple reference biologics, reports the American Journal of Managed Care (AJMC).